The preindex median charges were $90 for the fluticasone propionate group, $120 for the montelukast group and $118 for the zafirlukast group.
The preindex mean charges were $445 for the fluticasone propionate group, $355 for the montelukast group and $838 for the zafirlukast group.
Charges, both unadjusted and adjusted, were reported. The charges appear to have been adjusted, using a regression model, to account for highly skewed data, but details were not given.
With fluticasone propionate, the unadjusted total charge for asthma care in the postindex group was $576 (95% CI: 413 - 738) and the adjusted charge was $528 (95% CI: 508 - 547), for all ages.
For the group aged over 12 years, the unadjusted charge was $602 (95% CI: 421 - 791) and the adjusted charge was $536 (95% CI: 510 - 562).
For the 4- to 11-year-olds, the unadjusted charge was $426 (95% CI: 299 - 554) and the adjusted charge was $425 (95% CI: 386 - 463).
With montelukast, the unadjusted total charge for asthma care in the postindex group was $902 (95% CI: 689 - 1,116) and the adjusted charge was $967 (95% CI: 931-1,003), for all ages.
For the group aged over 12 years, the unadjusted charge was $893 (95% CI: 652 - 1,134) and the adjusted charge was $961 (95% CI: 916 - 1,007).
For the 4- to 11-year-olds, the unadjusted charge was $959 (95% CI: 550 - 1,369) and the adjusted charge was $932 (95% CI: 837 - 1,028).
With zafirlukast, the unadjusted total charge for asthma care in the postindex group was $1,417 (95% CI: 775 - 2,060) and the adjusted charge was $1,359 (95% CI: 1,300 - 1,419), for all ages.
For the group aged over 12 years, the unadjusted charge was $,1420 (95% CI: 764 - 2,076) and the adjusted charge was $1,391 (95% CI: 1,317 - 1,465).